Session 1191: Gene Therapy, Part 2

Cochair(s): S Ikehara, J Gibbs
Date: Mon 11 February 2002, Time: 11:30 - 13:00
Location: CIS Auditorium

Oral Presentations

Time Number Title / Authors / Affiliations
11:30 528 Gene therapy for prostate cancer by targeting DNA-damage response.
I Trofimova, A Dimtchev, M Jung, D Rosenthal, M Smulson, A Dritschilo, V Soldatenkov
Georgetown University Medical School, Washington, DC United States
11:45 529 Cell-type-specific gene delivery for in vivo gene therapy
RD Dornburg
Thomas Jefferson University, Philadelphia, PA United States
12:00 530 Translational control of malignancy and chemoresistance in breast cancer cells: antiapoptotic function of the translational factor eIF4E
SA Avdulov, S Li, D Burrichter, M Peterson, N Sonenberg, PB Bitterman, VA Polunovsky
1Department of Medicine, University of Minnesota, Minneapolis, MN United States, 2Department of Biochemistry, McGill University, Quebec, Canada
12:15 531 *IN VIVO targeted transfection of IL-3 gene into murine haematopoietic progenitor cells through CD117
A Chapel, M Bensidhoum, C Germain, P Poncet, C Goupy, G Chavanel, F Hirsch, D Thierry
1Département de Protection de la santé de l'Homme et de Dosimétrie, Section Autonome de Radiobiologie Appliquée à la Médecine, Fontenay-aux-Roses, France, 2Institut Pasteur, Unité d'Immuno-Allergie, Paris, France, 3Equipe d'Immunologie Cellulaire et de Transplantation, Villejuif, France
12:30 532 Synthesis and biological evaluation of polyamine vectors as new drug delivery agents
O Phanstiel
Center for Discovery of Drugs and Diagnostics, Department of Chemistry, University of Central Florida, Orlando, FL
12:45 533 Selective killing of cancer cells through translational regulation of the HTK/GCV gene therapy system
D Fatta, RP Chervenak, Y Li, A De Benedetti
1Department of Biochemistry & Molecular Biology and the Feist-Weiller Cancer Center, USA, 2Department of Microbiology and Immunology, Louisiana State University Health Sciences Center. 1501 Kings Highway. Shreveport, USA
13:00 534 Intramuscular and intratumoral gene electrotransfer for gene therapy of cancer
D Scherman
UMR 7001 CNRS / ENSCP Pierre et Marie Curie University / Aventis Company, Vitry-sur-Seine, France